|
Real-time Estimate
Tradegate
10:16:18 02/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 4.820 EUR | +1.26% |
|
+1.28% | -17.93% |
| 09-17 | Novo, Orbis sign up to $1.4 billion deal to develop oral drugs | RE |
| 08-20 | ORBIS AG Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
Evolution of the Average Target: ORBIS AG
Evolution of the Target Price: ORBIS AG
Changes in Analyst Recommendations: ORBIS AG
21d7.w63X6r6mbnlLu0wFb2-DMdswF8iqUK8IGHU0aLT_pvE.qeCljvL-GjYs93VkGiXFX-tgZJj_D9hnQkJkPua27KPz---B_P4LITjRLw~b585169b5f3cadb3f67cb854404028a6
| Consensus | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Objective/dr gap | ||
|---|---|---|---|---|---|---|
 | - | - | +143.7% | |||
| +6.64% | |||||
| +19.39% | |||||
| -4.04% | |||||
| +24.31% | |||||
| +0.54% | |||||
| +18.71% | |||||
| +35.24% | |||||
| +59.85% | |||||
| +20.79% | |||||
| Average | +32.51% | |||||
| Weighted average by Cap. | +14.90% |
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
4.760EUR
Average target price
11.60EUR
Spread / Average Target
+143.70%
High Price Target
11.60EUR
Spread / Highest target
+143.70%
Low Price Target
11.60EUR
Spread / Lowest Target
+143.70%
Analyst Consensus Detail
Consensus revision (last 18 months)
- Stock Market
- Stocks
- OBS Stock
- Consensus ORBIS AG
Select your edition
All financial news and data tailored to specific country editions
